Metraipolis › archive › dc_a50ee711ca27
Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma — Europe PMC PMID:40926353
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40926353
- DOI
- 10.1111/pcmr.70050
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:12:56.523Z
- SHA-256 of the archived text
d193df162fc120862761e3607f67c0cef51d5fb131846952f2bb6a35452898a2- Stable URL of this page
https://metraipolis.com/documento/dc_a50ee711ca27
How to cite
Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma — Europe PMC PMID:40926353 — Europe PMC (en), https://europepmc.org/article/MED/40926353 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a50ee711ca27 (Metraipolis archive dc_a50ee711ca27, sha256 d193df162fc120862761e3607f67c0cef51d5fb131846952f2bb6a35452898a2)
BibTeX
@misc{dca50ee711ca27,
title = {Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma — Europe PMC PMID:40926353},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40926353},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a50ee711ca27; sha256 d193df162fc120862761e3607f67c0cef51d5fb131846952f2bb6a35452898a2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40926353. Agents can read the archived copy with the MCP tool read_document.